Real-time enrollment status for this blood cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:51 AM UTC
| NCT Number | NCT06533579 |
| Recruiting Status | Recruiting |
| Condition | Blood Cancer |
| Phase | PHASE1 |
| Target Enrollment | 32 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Vironexis Biotherapeutics Inc. |
| Last Updated on CT.gov | August 6, 2026 (Aug 6, 2026) |
As of October 16, 2026: Clinical trial NCT06533579 is currently recruiting participants. This phase1 study for blood cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by Vironexis Biotherapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06533579 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06533579 was last updated Aug 6, 2026 (August 6, 2026). HelloStudys verifies this status automatically.